Rift Valley Fever Outbreak Toolbox

Rift Valley Fever Outbreak Toolbox

Updated | April 2024

WHO/TDR /Simon Lim
© Credits

Welcome to the Rift Valley Fever Outbreak Toolbox

Key reference documents

Case definitions

WHO suggested outbreak case definition

Suspected case
  • Any person with clinical features suggestive of RVF1 AND had contact with sick or dead animals (sheep, goats, cattle, camels), or their products, in the 15 days prior to onset of symptoms.
    Confirmed case
    • Any suspected or probable case with a laboratory positive result (detection of virus by RT-PCR, positive IgM or IgG seroconversion2, or virus isolation).

     

    Discarded case
    • Any suspected or probable case with a negative laboratory result (showing no specific antibodies, RNA or specific detectable antigens).

    WHO surveillance case definition

    Integrated Disease Surveillance and Response (Brazzaville: World Health Organization Regional office for Africa; 2019).

    Early disease: 

    Acute febrile illness (axillary temperature >37.5 ºC or oral temperature of >38.0ºC) of more than 48 hours duration that does not respond to antibiotic or antimalarial therapy, and is associated with:

    • Direct contact with sick or dead animals or its products
    • Recent travel (during last week) to, or living in an area where, after heavy rains, livestock die or abort, and where RVF virus activity is suspected/confirmed
    • Abrupt onset of any one or more of the following: exhaustion, backache, muscle pains, headache (often severe), discomfort when exposed to light, and nausea/vomiting
    • Nausea/vomiting, diarrhoea or adnominal pain with one or more of the following: severe pallor (or Hb < 8 gm/dL); low platelets (thrombocytopenia) as evidence by presence of small skin and mucous membrane haemorrhages (petechiae) (or platelet count < 100x109/dL), or evidence of kidney failure (oedema, reduced urine output (or creatinine > 150 mol/L) OR
    • Evidence of bleeding into skin, bleeding from puncture wounds, from mucous membranes or nose, from gastrointestinal tract and unnatural bleeding from vagina, OR
    • Clinical jaundice (3-fold increase above normal of transaminases).

    Late stages of diseases or complications (2-3 weeks after onset): 

    Patients who have experienced, in the preceding month a flu-like illness, with clinical criteria, who additionally develop the following:

    • CNS manifestations which resemble meningoencephalitis AND/OR:
    • Unexplained visual loss, OR:
    • Unexplained death following sudden onset of acute flu-like illness with haemorrhage, meningoencephalitis, or visual loss during the preceding month.

    1. Early signs and symptoms suggestive of RVF commonly include: suden onset of fever (>38°C) with headache, myalgia and/or arthralgia, and no other identified cause (e.g. malaria), or spontaneous miscarriage without other identified aetiologies.

    2. A rise in IgG antibody titers between two consecutive samples taken 2-weeks apart.


     

     

    Data collection tools

    • Case investigation forms: Not Available
    • Line list: Not available. 
    • Electronic tools: Not available

    Laboratory confirmation

    Response tools and resources

    Training

    •  Rift Valley Fever: Introduction. Open WHO Outbreak channel (Geneva: World Health Organization; 2017).

    Other resources